Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,628
datasets available to search
ShareScore release 0.9.0
Dataset results
1,628 results for “type safety”
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
ClinicalTrials.gov study NCT02182830. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
ClinicalTrials.gov study NCT03061214. IPD Sharing: YES. Countries: 7. Publications: 2.
Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy
ClinicalTrials.gov study NCT02002884. IPD Sharing: NO. Countries: 6. Publications: 2.
A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01880736. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01106651. IPD Sharing: Not stated. Countries: 17. Publications: 8.
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT02607865. IPD Sharing: YES. Countries: 15. Publications: 9.
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT02058160. IPD Sharing: Not stated. Countries: 18. Publications: 10.
Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02229227. IPD Sharing: YES. Countries: 14. Publications: 1.
Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
ClinicalTrials.gov study NCT01106586. IPD Sharing: Not stated. Countries: 17. Publications: 3.
A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6
ClinicalTrials.gov study NCT00686075. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01023581. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT03117998. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01930188. IPD Sharing: Not stated. Countries: 18. Publications: 16.
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
ClinicalTrials.gov study NCT00773734. IPD Sharing: Not stated. Countries: 2. Publications: 8.
Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis
ClinicalTrials.gov study NCT01988103. IPD Sharing: YES. Countries: 1. Publications: 3.
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01652729. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes
ClinicalTrials.gov study NCT00136916. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
ClinicalTrials.gov study NCT01620489. IPD Sharing: Not stated. Countries: 6. Publications: 4.
Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
ClinicalTrials.gov study NCT04886518. IPD Sharing: NO. Countries: 2. Publications: 1.
A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy
ClinicalTrials.gov study NCT01649297. IPD Sharing: Not stated. Countries: 18. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.